Safety of antiviral and anti-inflammatory drugs prolonging QT interval in patients with coronavirus disease 2019: an opinion of the Heart Rhythm Section of the Polish Cardiac Society

Kardiol Pol. 2020 May 25;78(5):493-497. doi: 10.33963/KP.15354. Epub 2020 May 11.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Anti-Infective Agents / adverse effects
  • Anti-Inflammatory Agents / adverse effects
  • Antiviral Agents / adverse effects*
  • Arrhythmias, Cardiac / chemically induced*
  • Arrhythmias, Cardiac / physiopathology
  • COVID-19
  • Clinical Decision-Making
  • Coronavirus Infections / complications
  • Coronavirus Infections / drug therapy*
  • Electrocardiography
  • Humans
  • Long QT Syndrome / chemically induced*
  • Long QT Syndrome / physiopathology
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / drug therapy*
  • Poland
  • Societies, Medical

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Anti-Inflammatory Agents
  • Antiviral Agents